EP2861576
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.5.2013EP published:
10.1.2018EP application number:
13730655.1
EPO information:
European Patent Register
Max expiry date:
8.5.2033
Title:
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
Timeline
Today
9.5.2013EP application
10.1.2018EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
FURET, PascalAddress:
Basel, CH
Name:
GROTZFELD, Robert MartinAddress:
Basel, CH
Name:
JONES, Darryl BrynleyAddress:
Basel, CH
Name:
MANLEY, PaulAddress:
Basel, CH
Name:
MARZINZIK, AndreasAddress:
Basel, CH
Name:
PELLE, Xavier Francois AndreAddress:
Basel, CH
Name:
SALEM, BahaaAddress:
Basel, CH
Name:
SCHOEPFER, JosephAddress:
Basel, CH
Name:
JAHNKE, WolfgangAddress:
Basel, CH
Priority
Number:
201261647174 PDate:
15.5.2012Country:
US
Number:
201361789842 PDate:
15.3.2013Country:
US
Classification
Categories:
C07D 401/04, C07D 401/14, C07D 403/10, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/10, C07D 417/14, A61K 31/4439, A61K 31/444, A61K 31/496, A61K 31/5377, A61P 31/00